v3.26.1
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Stock Options and SAR Activity
A summary of stock option and SAR activity for the three months ended March 31, 2026 is as follows (in millions, except share amounts which are reflected in thousands, per share amounts, and years):
SARs Outstanding Number of SARsOptions Outstanding Number of SharesWeighted-Average Exercise Price Per ShareWeighted-Average Remaining Contractual Life (in years)Aggregate Intrinsic Value
As of December 31, 202516 5,868 $48.72 4.79$194 
Granted— 517 $75.95 
Exercised(3)(61)$19.79 
Canceled and forfeited— (73)$59.51 
As of March 31, 202613 6,251 $51.14 4.77$136 
Exercisable as of March 31, 202613 2,445 $31.23 3.17$101 
Schedule of Restricted Stock Units Activity
The following table summarizes the activity related to our RSUs for the three months ended March 31, 2026 (in thousands, except per share amounts):
Number of SharesWeighted-Average
 Grant-Date Fair
 Value per Share
Unvested and outstanding as of December 31, 202557,654 $65.69 
Granted32,057 $73.44 
Vested(8,936)$51.89 
Canceled and forfeited(2,198)$67.60 
Unvested and outstanding as of March 31, 202678,577 $70.36 
Schedule of Stock-Based Compensation Expense by Function The following table summarizes total stock-based compensation expense by function (in millions):
Three Months Ended March 31,
20252026
Operations and support$52 $60 
Sales and marketing24 25 
Research and development264 286 
General and administrative95 102 
Total$435 $473